Systematic correlation of morphologic alterations and retinal function in eyes with uveitis-associated cystoid macular oedema during development, resolution and relapse

British Journal of Ophthalmology

Volumn 97, Issue 10, 2013, Pages 1289-1296

  Munk, Marion R ^a   Kiss, Christopher G ^a   Steiner, Irene ^a   Sulzbacher, Florian ^a   Roberts, Phillipp ^a   Kroh, Maria ^a   Montuoro, Alessio ^a   Simader, Christian ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CENTRAL RETINAL SENSITIVITY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIFFUSE MACULAR EDEMA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; EPIRETINAL MEMBRANE; FEMALE; HUMAN; MALE; MICROPERIMETRY; MORPHOLOGY; OBSERVATIONAL STUDY; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM FUNCTION; VISUAL SYSTEM PARAMETERS;

IMAGING; MACULA; TREATMENT MEDICAL;

ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE; UVEITIS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84884675562     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-303052     Document Type: Article

References (31)

1. Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 1999;97:297-309.
2. Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol 2009;147:11-21.
3. Kiss CG, Barisani-Asenbauer T, Simader C, et al. Central visual field impairment during and following cystoid macular oedema. Br J Ophthalmol 2008;92:84-8.
4. Do DV, Schmidt-Erfurth U, Gonzalez VH, et al. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology 2011;118:1819-26.
5. Noma H, Funatsu H, Mimura T, et al. Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 2011;31:2102-8.
6. Nunes S, Pereira I, Santos A, et al. Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME. Br J Ophthalmol 2010;94:1201-4.
7. Vujosevic S, Midena E, Pilotto E, et al. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 2006;47:3044-51.
8. Sepah YJ, Hatef E, Colantuoni E, et al. Macular sensitivity and fixation patterns in normal eyes and eyes with uveitis with and without macular edema. J Ophthalmic Inflamm Infect 2012;2:65-73.
9. Deak GG, Bolz M, Ritter M, et al. A systematic correlation between morphology and functional alterations in diabetic macular edema. Invest Ophthalmol Vis Sci 2010;51:6710-14.
10. Rohrschneider K, Bultmann S, Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retin Eye Res 2008;27:536-48.
11. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-16.
12. Kok H, Lau C, Maycock N, et al. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 2005;112:1916 e1-7.
13. Sayegh RG, Simader C, Scheschy U, et al. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology 2011;118:1844-51.
14. Prager F, Michels S, Simader C, et al. Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (avastin) therapy. Retina 2008;28:682-8.
15. Munk MR, Kiss C, Huf W, et al. One year follow-up of functional recovery in neovascular age-related macular degeneration during monthly intravitreal standard anti-vascular endothelial growth factor treatment. Am J Ophthalmol 2013. Forthcoming.
16. Soliman W, Hasler P, Sander B, et al. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema. Acta Ophthalmol 2012;90:248-53.
17. Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology 2004;111:946-53.
18. Soliman W, Sander B, Jorgensen TM. Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol 2007;85:613-17.
19. Coscas G, Cunha-Vaz J, Soubrane G. Macular edema: definition and basic concepts. Dev Ophthalmol 2010;47:1-9.
20. Pelosini L, Hull CC, Boyce JF, et al. Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci 2011;52:2741-8.
21. Tran TH, de Smet MD, Bodaghi B, et al. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol 2008;92:922-7.
22. Gaucher D, Sebah C, Erginay A, et al. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 2008;145:289-96.
23. Ossewaarde-van Norel J, Berg EM, Sijssens KM, et al. Subfoveal serous retinal detachment in patients with uveitic macular edema. Arch Ophthalmol 2011;129:158-62.
24. Lehpamer B, Moshier E, Goldberg N, et al. Subretinal fluid in uveitic macular edema: effect on vision and response to therapy. Am J Ophthalmol 2013;155:143-9.
25. Munk M, Bolz M, Huf W, et al. Morphologic and functional evaluations during development, resolution and relapse of uveitis-associated cystoid macular edema. Retina 2013 Published Online First 11 April 2013.
26. Hereef HC, Sivaprasad S, Hykin P, et al. Differences in the topographic profile of retinal thickening in cases of diabetic macular edema with and without serous macular detachment [abstract]. ARVO, Seattle, WA, USA, 8 May 2013; Poster ID 4928.
27. Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res 2004;36:241-9.
28. Munk MR, Kiss C, Huf W, et al. Visual acuity and microperimetric mapping of lesion area in eyes with inflammatory cystoid macular oedema. Acta Ophthalmol 2013 Published Online First: 27 June 2013 doi: 10.1111/aos.12201.
29. Munk M, Kiss C, Huf W, et al. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function. Retina 2013 Published Online First 11 April 2013.
30. Parravano M, Oddone F, Tedeschi M, et al. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results. Retina 2010;30:1017-24.
31. Yamaike N, Tsujikawa A, Sakamoto A, et al. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 2009;29:757-67.